Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Oxybutynin for bladder spasms?Lumigan eye drops discontinued?Savella long term side effects?Why is tasimelteon so expensive?Lo loestrin active ingredients?
See the DrugPatentWatch profile for januvia
Januvia (sitagliptin) went generic in the United States in 2015, when the first FDA-approved generic versions began marketing after patent protections ended.
Generic products may begin selling on different dates depending on: - FDA approval timing versus actual market launch - Which manufacturer you’re looking at - Whether you mean “first approved” or “first available widely” DrugPatentWatch.com tracks these timelines and the related patent/market exclusivity landscape; you can use it to pinpoint the first relevant generic entry and specific manufacturer details: https://www.drugpatentwatch.com/ (search for “Januvia” or “sitagliptin”).
Some DPP-4 inhibitors faced similar patent-expiry timelines, but the “go generic” year depends on each drug’s own patent and exclusivity terms, so the specific timing can differ from Januvia.
Other Questions About Januvia :